You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The company was founded last year as a spinoff of PSL's ESPCI Paris to develop a high-throughput single-cell analysis platform.
The US nonprofit founded by the UK's Wellcome Trust will fund collaborative research projects to build multiscale and multimodal "tissue time machines."
The Bruker-backed startup will make technology whose data could be complementary to both NGS-based Hi-C assays and spatial transcriptomics methods.
Fresh off a name change, the company last week introduced a monitoring platform for new SARS-CoV-2 variants that alerts diagnostic test makers to potential problems.
The Taiwan-based startup aims to publish data showing the instrument's prognostic value in colorectal cancer, as well as launch a new version, by this summer.